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Ectopic Over-expression of Oncogene Pim-2 Induce Malignant 
Transformation of Nontumorous Human Liver Cell Line L02
In order to prove that ectopic over-expression of Pim-2 could induce malignant 
transformation of human liver cell line L02, three groups of cells were set up including 
human liver cell line L02 (L02), L02 cells transfected with Pim-2 gene (L02/Pim-2) and L02 
cells transfected with empty-vector (L02/Vector). Pim-2 expression levels were detected. 
The morphology, proliferation level, apoptosis rate and migration ability of the cells were 
detected respectively. Then the cells were subcutaneously inoculated into athymic mice and 
the microstructures of the neoplasm were observed. Compared with the controls, Pim-2 
expression levels were significantly higher in L02/Pim-2 cells (P<0.05), and their 
morphology had obvious malignant changes. They also showed a significantly increased 
proliferation rate (P<0.05) and migration capacity (P<0.05), as well as a significantly 
decreased apoptosis rate (P<0.05). Only the athymic mice inoculated with L02/Pim-2 cells 
could generate neoplasm, and the morphology of the neoplasm coincided with that of the 
hepatoma. The results manifest that ectopic Pim-2 gene could be stably expressed in L02/
Pim-2 cells. Both the morphological and biological changes of L02/Pim-2 cells demonstrate 
the trend of malignant transformation. L02/Pim-2 cells could generate hepatoma in 
athymic mice. In conclusion, Pim-2 could induce malignant transformation of human liver 
cell line L02.
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ORIGINAL ARTICLE
Oncology & Hematology
INTRODUCTION
The activation of oncogene and the inactivation of anti-onco-
gene are two basic molecular biological events in the develop-
ment of malignant tumors. Pim-2 is a newfound oncogene and 
its protein product belongs to the serine/threonine kinase Pim 
(proviral integration of Moloney virus) family (1). It has a strong 
effect on inhibiting the apoptosis of tumor cells without cell 
specificity, thus plays an important role in the development of 
several kinds of tumors such as lymphoma, leukemia, multiple 
myeloma and prostatic carcinoma, etc. (1-3). Recently, the re-
searches on Pim-2 are mainly limited in lymph and hematopoi-
etic system (4, 5). There are few reports focusing on the relation-
ship between Pim-2 and hepatocellular carcinoma. It has been 
proved that both growth factors and glucose are needed in the 
anti-apoptotic effect of Pim-2 (1, 6), and it is well known that liv-
er has dual blood supply which can offer abundant growth fac-
tors and glucose. What’s more, our previous studies have found 
that the expression level of Pim-2 mRNA and protein were sig-
nificantly higher in hepatocellular carcinoma tissues than that 
in normal liver tissues (7). Based on these findings, we presumed 
that Pim-2 may take part in the tumorigenesis of hepatocellular 
carcinoma. In our experiment, Pim-2 gene was successfully tran–
sfected into the nontumorigenic human liver cell line L02. And 
the biological behaviors of the transfected cells were detected. 
We expected to confirm that the non tumorigenic human liver 
cell line L02 could be malignantly transformed when Pim-2 was 
over expressed. It would be supportive to our previous hypoth-
esis that Pim-2 takes part in the tumorigenesis of hepatocellular 
carcinoma.
MATERIALS AND METHODS
Cell culture and transfection
Three groups of cells were set up in our experiment: L02 cells 
transfected with Pim-2 gene (L02/Pim-2, group A), L02 cells 
transfected with empty-vector (L02/vector, group B), the non 
tumorigenic human liver cell line L02 (L02, group C). The con-
struction of the eukaryotic cell expression vector pCI-neo-Pim-2 
and the transfection were performed as described previously (7). 
Each group of cells were cultured in the RPMI 1640 medium con-
taining 10% betal bovine serum (FBS) and 50 μg/mL Ampicillin 
at 37°C with 5% CO2 for 20 generations. 
Reverse transcription PCR
Total RNA was extracted from each group of cells respectively Ren K, et al.  •  Pim-2 Induce Malignant Transformation of L02 Cells
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using SV total RNA isolation kit (Promega, USA). The integrality of 
the total RNA was verified by electrophoresis. Specific primers 
for Pim-2 and GAPDH were synthesized according to the pub-
lished sequences: Pim-2 forward 5’-ATGTTGACCAAGCCTC-
TACA-3’ , reverse 5’-TTAGGGTAGCAAGGACCAGG-3’; GAPDH 
forward 5’-CGGGAAACTGTGGCGTGAT-3’ , reverse 5’-CAAAG–
GTGGA–GGAGTGGGT-3’ . The constituents of the reaction sys-
tem were listed as below: MgCl2 (25 mM) 10 μL, 10×RNA PCR 
buffer 5 μL, RNase free deionized water 19 μL, dNTP mixture (10 
mM) 5 μL, RNase inhibitor (40 U/μL) 1 μL, AMV retroviridase (5 
U/μL) 1 μL, AMV-Optimized Taq (5 U/μL) 1 μL, Pim-2 forward 
primer (20 pM/μL) 2 μL, Pim-2 reverse primer (20 pM/μL) 2 μL, 
total RNA sample 4 μL, and the total bulk volume were 50 μL.
  The reverse transcription reactions were carried out at 50°C 
for 30 min, and then the reaction system were heated to 94°C 
for 2 min, followed by a course of 35 cycles with 94°C for 30 sec, 
55°C for 30 sec and 72°C for 1 min in each cycle. After the last 
cycle, a final extension step was taken at 72°C for 7 min. Finally, 
the RT-PCR products were electrophoresed on 1% agarose gels 
and quantified by UVP gel analysis system. The experiment was 
repeated three times for each group.
Immunocytochemistry
Each group of cells was inoculated on a cover slip respectively, 
fixed with 4% paraformaldehyde for 30 min and washed with 
phosphate buffered solution (PBS). In order to inactivate endog-
enous peroxidase, the cells were incubated with 3% H2O2 for 10 
min and then washed with PBS. Then goat serums were added 
in order to reduce nonspecific binding. Cells were incubated 
with goat-anti-human Pim-2 polyclonal antibody (1:200) (sc-
13675, Santa Cruz Biotechnology) at 37°C for 1 hr and washed 
with PBS. Then secondary antibodies were added and kept at 
37°C for 0.5 hr followed by a washing with PBS. Stept Avidin Bio-
tin Complex was added next and kept at 37°C for 30 min. Then 
the cells were washed with PBS and diaminobenzidine coloring 
reagent was added. The cover slips were dyed with hematoxylin 
and dehydrated with alcohol, then cleaned in xylene and mount-
ed with gum. Finally, the results were observed under micro-
scope. The experiment was repeated three times for each group.
Cell morphology observation
Each group of cells was incubated respectively until 80% areas 
of the culture plate were covered. Then the medium was poured 
out and the cells were washed with PBS. Finally, the morpholo-
gy of the cells was observed under the inverted microscope. The 
experiment was repeated three times for each group.
Analysis of the cell migration rate
Millicell rooms (Millipore) were used for cell migration ability 
assay. There were upper layer and lower layer in the Millicell 
room with a membrane in the middle which had micro-holes 
for cells to pass. The counts of the migrated cells in a certain pe-
riod of time could be regarded as their migrating ability. Each 
group of cells was cultured in the RPMI 1640 medium with 10% 
FBS and then transferred into another RPMI 1640 medium with-
out FBS. After 24 hrs’ incubation, the supernatant of the culture 
fluid was collected and cryopreserved as conditioned medium 
for later use. The optimal time point for detecting was set at 4-hr 
according to preliminary experiment. Three Millicell rooms were 
prepared for each group of cells. The cell density was adjusted 
to 10
5/mL. 100 µL cell suspension were added into the Millicell 
room and 500 µL conditioned medium were added outside. 
Four hours later, the Millicell rooms were taken out and washed 
with PBS. Then the samples were fixed by 2% glutaraldehyde 
(GA) for 30 min and stained with Giemsa for 10 min. The cells 
in the upper layer of the microporous membrane were removed 
and the cells in the lower layer were counted under the inverted 
microscope. The experiment was repeated three times for each 
group.
Analysis of cell proliferation level
The cells was digested with 0.25% trypsin digestion and made 
into cell suspension of 2×10
4/mL. Two hundred µL cell suspen-
sion was added into each hole of the cell culture plate, 6 holes 
each group. Five pieces of such cell culture plates were prepared 
for and placed in the incubator at 37°C with 5% CO2. Five time 
points were set as 24 hr, 48 hr, 72 hr, 96 hr, and 120 hr after the 
incubation. Five plates were taken out respectively at five differ-
ent time points, one plate each time. Twenty μL methyl thiazolyl 
tetrazolium (MTT) was added into each hole away from light 
when each plate was taken out and then placed back into the 
incubator for 4 hr. Then the fluid in each hole was removed com-
pletely and 150 μL dimethyl sulfoxide was added in. Optical 
density of each sample was assayed by spectrophotometer at 
the wave length of 570 nm. Finally, the cell growth curve of each 
group was drawn on the base of the optical density data.
Analysis of cell apoptosis rate
After incubation for 48 hr, each group of cells was harvested and 
digested by 0.25% trypsin digestion. Then the cells were made 
into single cell suspension together with PBS and centrifuged 
3,000 rpm for 5 min. The cell density was adjusted to 10
6/mL.       
one mL cell suspension was put into a tube and centrifuged, and 
the supernatant was removed. The cells were washed with cold 
PBS twice and then suspended in 200 μL buffer. Ten μL Annex-
in V-FITC and 5 μL propidium iodide were added into each cell 
centrifugation tube and the reaction was developed away from 
light at room temperature for 15 min. Then 300 μL buffers were 
added in and the apoptosis rates of the cells were detected by 
flow cytometry (FCM). The experiment was repeated three times 
for each group. Ren K, et al.  •  Pim-2 Induce Malignant Transformation of L02 Cells
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Carcinogenic ability assay
15 male athymic mice were purchased from the experimental 
animal center of Chongqing Medical University and were ran-
domly divided into 3 groups with 5 mice in each group. The three 
groups of cells were respectively digested with trypsinization 
and centrifugated by 1,200 rpm for 5 min. The cells were then 
suspended with PBS and the density were adjusted to 10
7/mL. 
Each group of cells was accordingly inoculated to one group of 
athymic mice and each mouse was subcutaneously injected 
with 0.2 mL cell suspension at the right hind limb. The diame-
ters of the mass which appeared in the athymic mice several 
days after the inoculation were measured twice a week. The vol-
ume of the mass was calculated according to the following for-
mula: Volume (V)=A×B×C (A, B and C stand for the length, width 
and height of the mass respectively). Finally the tumor mass were 
cut down and made into different sections routinely according 
to different demands, and then observed under light microscope 
and transmission electron microscope (TEM) respectively. All 
animals received appropriate care in our experiments. 
Statistical analysis
The experimental data were analyzed using the SPSS 13.0 soft-
ware package. Average values were expressed as an arithmeti-
cal mean±standard deviation. The comparison between two 
groups was assessed by Student’s t test. P values less than 0.05 
were considered to be statistically significant.
RESULTS
The expression level of Pim-2 mRNA and protein 
In the RT-PCR result (Fig. 1), the band gray value represents the 
mRNA level of the corresponding cell group. We could see that 
Pim-2 mRNA is expressed in all the three groups of cells, but the 
expression level is obviously higher in L02/Pim-2 group than 
those in the other two groups. In the immunocytochemistry re-
sults (Fig. 2), Pim-2 protein is stained as buffy materials. We could 
see that Pim-2 protein is expressed in L02/Pim-2 group but not 
in the other two groups. 
Malignant changes in morphology, migrating rate, 
proliferation rate and apoptosis rate
In the early days after transfection, both L02/Pim-2 cells and 
L02/vector cells had no obvious change in their shapes. But af-
ter culturing for 20 generations, some differences were found. 
L02/Pim-2 cells were irregular fusiform of different size; and 
many small protuberances were observed (Fig. 3A), while L02/
vector cells still had no obvious change in shape (Fig. 3B). The 
shapes of L02 cells were always regular polygon or ellipse in con-
cordant size constantly (Fig. 3C). 
  In the migration ability analysis, the average number of the 
migrated cells is 95.1±4.75/HP in L02/Pim-2 group (Fig. 4A), 
while 72.2±5.67/HP in L02/vector group (Fig. 4B) and 75.0±6.57/ 
HP in L02 group (Fig. 4C). Compared with the controls, much 
more cells in the L02/Pim-2 group migrate through the micro-
porous membrane within the same time period. The statistical 
data also show significant difference between L02/Pim-2 group 
and the other two groups (P<0.05), but no significant differenc-
es between the L02/vector group and the L02 group (Fig. 4D). 
  In the proliferation level analysis, the detailed OD570 values 
of the different cell groups in different time points are shown in 
Table 1. We could see that no significant differences in the OD570 
value were found among the three groups of cells during the first 
day. In the next four days, the OD570 value of the cells in the L02/ 
Fig. 1. Semi-quantitative RT-PCR of Pim-2 mRNA in the three groups of cells. The band 
gray value represents the mRNA level of the corresponding cell group. Pim-2 mRNA 
was expressed in all the three groups of cells but the expression level was significantly 
higher in L02/Pim-2 group (A) than that in L02/vector group (B) and L02 group (C). 
M, marker.
100
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250
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750
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Fig. 2. Immunocytochemistry of Pim-2 protein in the three 
groups of cells. Buffy materials (arrow shows) are found in 
the cytoplasm and nucleus of the L02/Pim-2 group cells 
(A) but not in the L02/vector group (B) and L02 group (C). 
The buffy materials were regarded as Pim-2 protein. It 
indicated that the expression level of Pim-2 protein was 
significantly higher in L02/Pim-2 group than that in the 
L02/vector group and the L02 group (×200).  B A CRen K, et al.  •  Pim-2 Induce Malignant Transformation of L02 Cells
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Pim-2 group significantly increased compared with those in the 
other two groups (P<0.05), but no significant differences were 
found between the L02/vector group and the L02 group. 
  In the apoptosis rate analysis, the FCM results (Fig. 5) show 
that the apoptosis rate is 2.3±0.9% in L02/Pim-2 group, while 
5.5±0.4% in L02/vector group and 5.7±1.5% in L02 group. The 
statistical analysis showed significant difference between L02/
Pim-2 and the other two groups (P<0.05), but no significant dif-
ference between the L02/vector group and the L02 group. 
Production of carcinoma in athymic mice
Nine days after the inoculation, a neoplastic mass was firstly 
found in one athymic mouse which was inoculated with L02/
Pim-2 cells, and neoplasmas were found in all the 5 athymic 
mice of this group 21 days after the inoculation, with the aver-
age volume of 0.6×0.5×0.3 cm (Fig. 6). But no mass was found 
in the mice inoculated with L02/vector cells or L02 cells through-
out our experiment (data not shown). 
  The histology of the mass under light microscope shows ob-
viously disordered structure with large areas of necrotic tissue. 
The cells have marked cellular atypia, with giant nucleus, aug-
mented karyoplasmic ratio, clear chromatospherite and preva-
lent mitosis, especially pathological mitosis (Fig. 7). Observed 
Fig. 3. The morphology of the cells in the three groups. 
After culturing for 20 generations, the cells in the L02/
Pim-2 group (A) are irregular fusiform shape of different 
size and many small protuberances are observed. The 
morphology of the cells in the Pim-2/vector group (B) and 
L02 group (C) are similar each other and they are all 
regular polygon or ellipse in concordant size (inverted 
microscope ×200).  B A C
B A C
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Fig. 4. Migrated cells of the three groups in the Millicell room. (A-C) More cells in the 
L02/Pim-2 group (A) than in the L02/vector group (B) and L02 group (C) migrate 
through the microporous membrane. (D) There is significant difference between group 
A and group B, C, but no significant differences between group B and group C (*P< 
0.05 vs. Group A; 
†P>0.05 vs. Group B; inverted microscope ×200).
Table 1. OD570 values of the three groups of cells in different time points
Group
Number of cell suspension  
samples in each group
OD values 
1 day 2 day 3 day 4 day 5 day
A 6 0.453±0.042 0.640±0.050 0.939±0.110 1.063±0.115 1.171±0.135
B 6 0.418±0.044  0.484±0.064*  0.716±0.095*  0.855±0.068*  0.956±0.109*
C 6 0.423±0.034    0.459±0.044*
,†    0.694±0.077*
,†    0.869±0.048*
,†    0.966±0.103*
,† 
No significant differences in the OD570 value were found among the three groups of cells during the first day. In the next four days, the OD570 value of the cells in group A 
significantly increased compared with those in the other two groups (P<0.05), but no significant differences were found between the group B and group C. (Group A: L02/Pim-
2; Group B: L02/vector; Group C: L02; *P<0.05 vs. Group A; 
†P>0.05 vs. Group B).
Fig. 5. Apoptosis rate of the three groups of cells. The data of flow cytometry results 
show that the apoptosis rate of group A is significantly lower than that in the other two 
groups (B, C) (*P<0.05 vs. Group A), and no significant differences are found between 
group B and group C (
†P>0.05 vs. Group B). (Group A: L02/Pim-2; Group B: L02/
vector; Group C: L02).
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for malignant transformation trend. Our results also found that 
L02/Pim-2 cells had high proliferation rate and low apoptosis 
rate. This could be regarded as another evidence. Finally, we 
found that only L02/Pim-2 cells could produce neoplastic mass 
in athymic mice. What’s more, the histology of the neoplasm 
were coincident to that of malignant tumors. This could be re-
garded as the most direct evidence. Based on these findings, it 
was believed that ectopic overexpression of Pim-2 could induce 
malignant transformation of nontumorous human liver cell line 
L02 cells. This conclusion is supportive to our previous presump-
tion that Pim-2 may take part in the tumorigenesis of hepato-
cellular carcinoma, and was in accordance with the researches 
on Pim-2 in lymph and hematopoiesis system tumors (8-10).
  In this experiment, we presented a series of phenomenon to 
prove that Pim-2 could induce malignant transformation of non-
tumorous human liver cell line L02 cells, but we haven’t got the 
detailed mechanism. There is no doubt that clarifying the signal 
B
D
A
C
Fig. 7. The histology of the neoplastic tissue under light microscope. (A, B) The 
neoplastic tissue shows structurally disordered, with large areas of necrosis tissue 
(H&E, ×200); (C, D) The cells have marked cellular atypia, with giant nucleus, 
augmented karyoplasmic ratio, clear chromatospherite and prevalent mitosis, 
especially pathological mitosis (H&E, ×400).
B
D
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C
Fig. 6. The neoplastic mass found in the athymic mice which were inoculated with 
L02/Pim-2 cells. The first neoplasma was found in the 9th day after the inoculation, 
and in the 21st day, all the athymic mice in this group produced neoplasmas (A, B), 
with the average volume of 0.6×0.5×0.3 cm (C, D).
Fig. 8. The ultrastructure of the neoplastic cells 
under TEM. (A) Much more smooth endoplasmic 
reticulum (arrow) are found (TEM ×5,000); (B) The 
cells have large and irregular nucleus with profound 
umbilication (white arrow). Few giant mitochondria 
are found in the cytoplasm. Big chromatospherite 
or even multiple nucleoli are also found (TEM 
×7,000); (C) Multi-euchromatin (double arrows) 
are found in the nuclues (TEM ×8,000). B A C 2 µm 2 µm 2 µm
under the transmission electron microscope (TEM), the neoplas-
tic cells have diverse sizes and irregular shapes. More smooth 
endoplasmic reticulum (SER) and fewer giant mitochondria are 
found in the cytoplasm. The nuclei become large and irregular 
with profound umbilication and multi-euchromatin. Large chro-
matospherite or even multiple nucleoli are also found (Fig. 8). 
DISCUSSION
As a precondition of the whole experiment, the relative high ex-
pression level of Pim-2 mRNA and protein in L02/Pim-2 cells 
proved that our transfection was successful and that ectopic Pim-
2 could be stably expressed in L02/Pim-2 cells. As a pathologi-
cal common sense, the morphologic changes of the L02/Pim-2 
cells found in our experiment indicated an increased mobility, 
and the following migration ability experiment confirmed this 
inference. Increased mobility could be regarded as an evidence Ren K, et al.  •  Pim-2 Induce Malignant Transformation of L02 Cells
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transduction pathway of Pim-2 in hepatoma cells would provide 
more affirmative evidence for our presumption.
  Bad is a proapoptosis protein which belongs to Bcl-2 family. 
It is the only known phosphorylation substrate of Pim-2 kinase 
up to now (11). Pim-2 could phosphorylate Bad at multiple sites 
such as ser112, ser136 and ser155, etc. and different phosphor-
ylat ion site plays different role in the anti-apoptotic effect (12). 
Recently, a new research has found that Apoptosis Inhibitor 5 
(API-5) has a conserved sequence “RXRHXS”with Bad, and this 
conserved sequence is just the recognition site of Pim-2 kinase 
(13). Thus API-5 is now regarded as another possible substrate 
of Pim-2. What’s more, API-5 has been reported to be involved 
in the tumorigenesis of hepatocellular carcinoma (14). Based 
on these findings, API-5 can be presumed as another probable 
downstream target of Pim-2 in hepatocarcinoma cells.
  Another finding in lymphoma cells reports that the malignant 
transformation of lymphocyte by Pim-2 is dependent on NF-κB, 
and the anti-apoptotic effect of Pim-2 could be totally inhibit–
ed by NF-κB specific inhibitor (15). Pim-2 could activate NF-κB 
through a series of phosphorylation reactions. It is well known 
that NF-κB is an important transcription factor (16). It can in-
duce the transcription of several anti-apoptotic genes such as 
Bcl-2 and Myc, etc. (17). Different upstream stimulating signals 
could activate different transcription products, thus finding the 
key downstream factor of Pim-2 becomes the focus.
  Based on the related experimental results listed above, we have 
probed the relationship between Pim-2, NF-κB, and API-5 in or-
der to clarify the detailed anti-apoptosis mechanism of Pim-2 
in hepatocellular carcinoma. From the results of the clinical tis-
sue experiments, we found that all the three factors were highly 
expressed in hepatocellular carcinoma tissues but lowly expre–
ssed in paired noncancerous liver tissues and normal liver tis-
sues. The same results were found in cell experiments. What’s 
more, NF-κB specific repressor could inhibit the expression lev-
el of both NF-κB and API-5, but has no effect on Pim-2. The cell 
apoptosis rate is finally decided by the expression level of API-5 
other than Pim-2. Therefore, we could preliminarily draw the 
conclusion that Pim-2 could activate API-5 to inhibit the apop-
tosis of liver cells, and NF-κB is the key regulator (18). This result 
support our presumptive mechanism that Pim-2 could induce 
malignant transformation of nontumorous human liver cell line 
L02 cells.
  As a matter of fact, the anti-apoptotic mechanism of tumor 
cells is performed by several anti-apoptotic factors. The anti-
apoptotic pathways in the cells are just like a net and Pim-2 is 
only one point on the net. So there may be complex relationships 
between Pim-2 and its neighbors. It has been reported that many 
oncogenes could affect the anti-apoptotic effect of Pim-2, such 
as Akt, Bcl-2, Myc, and p53 (11, 12, 19, 20). Besides, there must 
be certain relationship among the members in Pim family (21-
24). Some researchers have found that Pim-1 is involved in the 
tumorigenesis of prostate cancer (2) and Pim-3 is reported to 
take part in the tumorigenesis of liver cancer too (25). The pos-
sible interaction between Pim-2 and these oncogenes in the pro-
cess of hepatoma tumorigenesis also needs further study. It is 
believed that further research of anti-apoptotic pathway by Pim-
2 will be beneficial to illuminate the pathogenesis of liver cancer.
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